Skip to content

Technology-Enabled Collaborative Care for Youth

Technology-Enabled Collaborative Care for Youth (TECC-Y): A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03610087
Acronym
TECC-Y
Enrollment
70
Registered
2018-08-01
Start date
2018-07-25
Completion date
2020-06-30
Last updated
2020-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factor, Metabolic Disease, Psychosis

Brief summary

The overall objective is to develop scalable interventions to address the physical health needs of patients affected by early psychosis. The objective of this project is to conduct a feasibility study of a high intensity technology-enabled collaborative care model (CCM) compared to lower intensity self-help modules and email support for early identification and treatment of cardio-metabolic risk factors in youth, ages 16-29, affected by early psychosis.

Interventions

Participants will have access via the online platform to the NAVIGATE self-help modules for physical activity, nutrition and quitting smoking with a list of community resources. Subjects will be sent a standard reminder emails once per week to complete their modules and connect with their main provider for any assistance.

Participants will receive individualized treatment planning, in collaboration with a Care Coordinator, and the Virtual Care Team (VCT). Interactive modules on physical activity, nutrition and quitting smoking will be provided via the online platform. the virtual team will be engaged to provide treatment and/or recommendations regarding the following: increasing physical activity, improving nutrition and diet, smoking cessation (psychosocial support plus medications), and medication adherence. Participants in this arm will have weekly check-ins with their assigned Care Coordinator where they will be able to discuss VCT recommendations, and progress on their goals.

Sponsors

Medical Psychiatry Alliance
CollaboratorOTHER
Trillium Health Centre
CollaboratorOTHER
The Hospital for Sick Children
CollaboratorOTHER
University of Toronto
CollaboratorOTHER
Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

* Ages 16 - 29 years * Clinician diagnosis of early psychosis (diagnosed in last 5 years) * Prescribed psychiatric medication, stable for 4 weeks * Access to telephone or internet through computer or mobile

Exclusion criteria

* Unable to provide consent * Unable to understand English

Design outcomes

Primary

MeasureTime frameDescription
Change in patient engagementBaseline, 6-weeks, 12-weeks, and 24-weeks.The primary outcome is patient engagement will be defined as participant activation in the program measured via self-report levels of perceived benefit from the program.

Secondary

MeasureTime frameDescription
Healthy Behaviour ChangeBaseline, 6-weeks, 12-weeks, and 24-weeks.The secondary outcome is to explore whether a CCM will help facilitate healthy behavioral changes in physical activity, nutrition, and smoking.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026